Morn­ing­side re­veals its lat­est biotech ef­fort, seek­ing to tack­le wide range of in­flam­ma­to­ry dis­eases

Morn­ing­side Ven­tures un­veiled its lat­est bet Thurs­day morn­ing, one where it’s al­ready pro­vid­ed more than $60 mil­lion in cash.

The VC firm un­veiled Adiso Ther­a­peu­tics …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER